Table 1.

Demographic data of the study cohort

	Gd− (n = 20)	Gd+ (n = 26)	p value
Age (mean ± SD)	31.15 ± 10.37	36.15 ± 8.65	0.081
Sex (male/female)			0.818
Male	6 (30.00%)	7 (26.92%)
Female	14 (70.00%)	19 (73.08%)
EDSS at sampling (median, Q1–Q2)	2 (1–2.5)	2 (1.5–2.13)	0.819
OCGB (N/P)			0.432
Negative	1 (5.26%)	0 (0.00%)
Positive	18 (94.74%)	25 (100.00%)
LS_OCMB (N/P)			0.393
Negative	14 (73.68%)	16 (61.54%)
Positive	5 (26.32%)	10 (38.46%)
T2 lesions			0.004
< 9 lesions	12 (66.67%)	4 (16.67%)
10–20 lesions	5 (27.78%)	10 (41.67%)
21–50 lesions	1 (5.56%)	8 (33.33%)
51–100 lesions	0 (0.00%)	2 (8.33%)

Gd− patients without gadolinium-enhanced lesions, Gd+ patients with gadolinium-enhanced lesions; SD standard deviation, OCBG oligoclonal IgG bands; N/P negative/positive, LS_OCMB lipid-specific oligoclonal IgM bands